Catalyst Wire Dossier Catalyst Wire Dossier
EMA approval · 2020-03-27

New gene therapy to treat spinal muscular atrophy (corrected)

View source ↗

Summary

The EMA announces a new gene therapy for spinal muscular atrophy, marking a significant regulatory milestone for treatment of the disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications